OBJECTIVE: To investigate whether motion correction improves glycosaminoglycan chemical exchange saturation transfer imaging (gagCEST imaging) of intervertebral discs (IVDs). MATERIALS AND METHODS: Magnetic resonance gagCEST imaging of 12 volunteers was obtained in lumbar IVDs at 3 T using a prototype pulse sequence. The data were motion-corrected using a prototype diffeomorphism-based motion compensation technique. For both the data with and that without motion correction (datac, datauc), CEST evaluation was performed using the magnetisation transfer ratio asymmetry (MTRasym) as a means of quantifying CEST effects. MTRasym and the signal-to-noise ratio (SNR) of the MTRasym map in the nucleus pulposus (NP) were compared for datac and datauc. A visual grading analysis was performed by a radiologist in order to subjectively quantify the quality of the MTRasym analysis (score 1: best quality, score 5: worst quality). Furthermore, a landmark analysis was performed in order to objectively quantify the motion between CEST images using the mean landmark distance dmean. RESULTS: MTRasym and SNR were significantly higher for the motion-corrected data than for the uncorrected CEST data (MTRasym(datac) = 3.77 % ± 0.95 %, MTRasym(datauc) = 3.41 % ± 1.54 %, p value = 0.001; SNR(datac) = 3.88 ± 2.04, SNR(datauc) = 2.77 ± 1.55, p value < 0.001, number of IVDs = 48). The visual grading analysis revealed a higher reliability for datac (maximum score = 2) compared with datauc (maximum score = 5). The landmark analysis demonstrated the superiority of the motion-corrected data (dmean(datac) = 0.08 mm ± 0.09 mm, dmean(datauc) = 0.36 mm ± 0.09 mm, p value = 0.001). CONCLUSION: Our study showed significant improvements in the ability to quantify CEST imaging in IVDs after the application of motion correction compared with uncorrected datasets.
OBJECTIVE: To investigate whether motion correction improves glycosaminoglycan chemical exchange saturation transfer imaging (gagCEST imaging) of intervertebral discs (IVDs). MATERIALS AND METHODS: Magnetic resonance gagCEST imaging of 12 volunteers was obtained in lumbar IVDs at 3 T using a prototype pulse sequence. The data were motion-corrected using a prototype diffeomorphism-based motion compensation technique. For both the data with and that without motion correction (datac, datauc), CEST evaluation was performed using the magnetisation transfer ratio asymmetry (MTRasym) as a means of quantifying CEST effects. MTRasym and the signal-to-noise ratio (SNR) of the MTRasym map in the nucleus pulposus (NP) were compared for datac and datauc. A visual grading analysis was performed by a radiologist in order to subjectively quantify the quality of the MTRasym analysis (score 1: best quality, score 5: worst quality). Furthermore, a landmark analysis was performed in order to objectively quantify the motion between CEST images using the mean landmark distance dmean. RESULTS: MTRasym and SNR were significantly higher for the motion-corrected data than for the uncorrected CEST data (MTRasym(datac) = 3.77 % ± 0.95 %, MTRasym(datauc) = 3.41 % ± 1.54 %, p value = 0.001; SNR(datac) = 3.88 ± 2.04, SNR(datauc) = 2.77 ± 1.55, p value < 0.001, number of IVDs = 48). The visual grading analysis revealed a higher reliability for datac (maximum score = 2) compared with datauc (maximum score = 5). The landmark analysis demonstrated the superiority of the motion-corrected data (dmean(datac) = 0.08 mm ± 0.09 mm, dmean(datauc) = 0.36 mm ± 0.09 mm, p value = 0.001). CONCLUSION: Our study showed significant improvements in the ability to quantify CEST imaging in IVDs after the application of motion correction compared with uncorrected datasets.
Authors: K Luoma; H Riihimäki; R Luukkonen; R Raininko; E Viikari-Juntura; A Lamminen Journal: Spine (Phila Pa 1976) Date: 2000-02-15 Impact factor: 3.468
Authors: Gizeaddis L Simegn; Andre J W Van der Kouwe; Frances C Robertson; Ernesta M Meintjes; Ali Alhamud Journal: Magn Reson Med Date: 2018-12-02 Impact factor: 4.668
Authors: Anja Müller-Lutz; Alexandra Ljimani; Julia Stabinska; Moritz Zaiss; Johannes Boos; Hans-Jörg Wittsack; Christoph Schleich Journal: MAGMA Date: 2018-05-14 Impact factor: 2.310
Authors: Daniel B Abrar; Christoph Schleich; Styliani Tsiami; Anja Müller-Lutz; Karl Ludger Radke; Neela Holthausen; Miriam Frenken; Matthias Boschheidgen; Gerald Antoch; Johanna Mucke; Philipp Sewerin; Juergen Braun; Sven Nebelung; Xenofon Baraliakos Journal: Arthritis Res Ther Date: 2020-09-17 Impact factor: 5.156
Authors: Miriam Frenken; Sven Nebelung; Christoph Schleich; Anja Müller-Lutz; Karl Ludger Radke; Benedikt Kamp; Matthias Boschheidgen; Lena Wollschläger; Bernd Bittersohl; Gerald Antoch; Markus R Konieczny; Daniel B Abrar Journal: Diagnostics (Basel) Date: 2021-02-26
Authors: Daniel B Abrar; Christoph Schleich; Sven Nebelung; Anja Müller-Lutz; Karl Ludger Radke; Miriam Frenken; Julia Stabinska; Alexandra Ljimani; Hans-Jörg Wittsack; Gerald Antoch; Bernd Bittersohl; Tobias Hesper Journal: MAGMA Date: 2020-07-28 Impact factor: 2.310
Authors: Lena M Wollschläger; Sven Nebelung; Christoph Schleich; Anja Müller-Lutz; Karl L Radke; Miriam Frenken; Matthias Boschheidgen; Max Prost; Gerald Antoch; Markus R Konieczny; Daniel B Abrar Journal: Diagnostics (Basel) Date: 2021-05-22